News articles about Petmed Express (NASDAQ:PETS) have trended positive on Wednesday, Accern reports. Accern ranks the sentiment of news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Petmed Express earned a news sentiment score of 0.27 on Accern’s scale. Accern also assigned headlines about the company an impact score of 44.4638214687092 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
These are some of the headlines that may have impacted Accern Sentiment’s scoring:
- A United Airlines Flight Attendant Forced a Passenger To Put Her Dog Into an Overhead Bin (Yes, the Worst Happened) (inc.com)
- A New Blackmark for United as Dog Dies in Overhead Bin (wsj.com)
- Does PetMed Express Inc’s (NASDAQ:PETS) Past Performance Indicate A Stronger Future? (finance.yahoo.com)
- Petmed Express Inc (PETS) Given Average Recommendation of “Hold” by Analysts (americanbankingnews.com)
- Top 3 Stocks To Buy – Yahoo Finance (finance.yahoo.com)
PETS has been the subject of several research reports. BidaskClub raised shares of Petmed Express from a “buy” rating to a “strong-buy” rating in a research note on Saturday, December 9th. Northcoast Research set a $58.00 price target on shares of Petmed Express and gave the stock a “buy” rating in a research note on Wednesday, January 3rd. Finally, ValuEngine raised shares of Petmed Express from a “hold” rating to a “buy” rating in a research note on Wednesday, February 7th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $42.80.
Petmed Express (NASDAQ:PETS) last released its earnings results on Monday, January 22nd. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.11. Petmed Express had a net margin of 12.84% and a return on equity of 34.04%. The business had revenue of $60.10 million during the quarter, compared to analysts’ expectations of $56.76 million. During the same period last year, the business earned $0.24 earnings per share. The firm’s revenue was up 13.6% on a year-over-year basis. analysts anticipate that Petmed Express will post 1.77 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Friday, February 16th. Investors of record on Monday, February 5th were paid a $0.25 dividend. The ex-dividend date of this dividend was Friday, February 2nd. This is a boost from Petmed Express’s previous quarterly dividend of $0.20. This represents a $1.00 annualized dividend and a dividend yield of 2.15%. Petmed Express’s dividend payout ratio (DPR) is currently 59.17%.
In related news, CEO Menderes Akdag sold 10,000 shares of the firm’s stock in a transaction on Monday, January 22nd. The shares were sold at an average price of $57.00, for a total value of $570,000.00. Following the completion of the transaction, the chief executive officer now directly owns 470,000 shares of the company’s stock, valued at $26,790,000. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Ronald J. Korn sold 5,000 shares of the firm’s stock in a transaction on Monday, January 29th. The shares were sold at an average price of $48.38, for a total transaction of $241,900.00. Following the completion of the transaction, the director now directly owns 68,833 shares of the company’s stock, valued at $3,330,140.54. The disclosure for this sale can be found here. Insiders sold 65,000 shares of company stock valued at $3,229,500 over the last three months. 4.00% of the stock is owned by company insiders.
About Petmed Express
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.